Pain Management
Alexza Pharmaceuticals announces initial results for the AZ-003 phase I clinical trial
Published in Pharma Law Weekly, January 23rd, 2007
The company has also completed a preliminary analysis of the top-line results of the clinical trial. AZ-003 is an inhalation product candidate being developed for the treatment of patients with acute pain episodes, including patients with breakthrough pain and postoperative pain.
The phase I clinical trial was conducted in opioid naive healthy volunteers in two stages. In Stage 1, the arterial pharmacokinetics (PK) of 25 micrograms of AZ-003 was compared to a 25 micrograms dose of fentanyl administered intravenously (IV)....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2007-01-23)
More Articles from Pharma Law Weekly
- Asbestosis
Studies conducted at Catholic Medical Center on asbestosis recently published - Bullying
Researchers from Indiana University discuss findings in bullying in children - Business & Finance
IRIDEX now current on its U.S. Securities & Exchange Commission filings - Business Update
Coalition America, Healthx and Bloodhound Technologies plan joint client conference - Business Update
Southern Oncology Association of Practices extends oncology services agreements with OTN, Onmark - Dementia Epidemiology
Researchers at Emory University release new data on dementia epidemiology - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
